secwatch.observer — SEC 8-K summary
======================================

Issuer:     CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV)
CIK:        0001801170
Form:       8-K
Filed at:   2023-01-20T23:59:59+00:00
Accession:  0001801170-23-000008
Event type: leadership
Sentiment:  neutral
Materiality: 0.45
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Clover Health CGO Prabhdeep Singh to depart March 31, 2023; consulting role set
-------------------------------------------------------------------------------

- Singh steps down as Chief Growth Officer effective March 31, 2023.
- Will provide consulting services for three months at $15,000/month.
- Company pays three months of COBRA premiums if elected.
- No successor announced; CEO Andrew Toy praised Singh's contributions.
- Separation and Consulting Agreement to be executed with standard release.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1801170/000180117023000008/0001801170-23-000008-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1801170/000180117023000008/clov-20230120.htm
  HTML page:      https://secwatch.observer/filing/0001801170-23-000008

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer